JP2022521973A5 - - Google Patents
Info
- Publication number
- JP2022521973A5 JP2022521973A5 JP2021549772A JP2021549772A JP2022521973A5 JP 2022521973 A5 JP2022521973 A5 JP 2022521973A5 JP 2021549772 A JP2021549772 A JP 2021549772A JP 2021549772 A JP2021549772 A JP 2021549772A JP 2022521973 A5 JP2022521973 A5 JP 2022521973A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- alcam
- soluble
- composition according
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962810628P | 2019-02-26 | 2019-02-26 | |
| US62/810,628 | 2019-02-26 | ||
| US201962933294P | 2019-11-08 | 2019-11-08 | |
| US62/933,294 | 2019-11-08 | ||
| PCT/US2020/019990 WO2020176682A1 (en) | 2019-02-26 | 2020-02-26 | Anti-cd6 antibody compositions and methods for treating lupus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521973A JP2022521973A (ja) | 2022-04-13 |
| JP2022521973A5 true JP2022521973A5 (enExample) | 2023-03-02 |
Family
ID=70009403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549772A Ceased JP2022521973A (ja) | 2019-02-26 | 2020-02-26 | 抗ｃｄ６抗体組成物およびループスを処置するための方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220143140A1 (enExample) |
| EP (1) | EP3930751A1 (enExample) |
| JP (1) | JP2022521973A (enExample) |
| CN (1) | CN113490511B (enExample) |
| AU (1) | AU2020229830A1 (enExample) |
| BR (1) | BR112021016967A2 (enExample) |
| CA (1) | CA3131299A1 (enExample) |
| MX (1) | MX2021010283A (enExample) |
| PH (1) | PH12021551994A1 (enExample) |
| SG (1) | SG11202109118XA (enExample) |
| WO (1) | WO2020176682A1 (enExample) |
| ZA (1) | ZA202107077B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009113083A1 (en) | 2008-03-14 | 2009-09-17 | Biocon Limited | A monoclonal antibody and a method thereof |
| JP2023552762A (ja) * | 2020-12-04 | 2023-12-19 | エクイリウム，インコーポレイテッド | Ｃｄ６ｈｉｇｈ細胞を選択的に標的化してｔｅｆｆ細胞の活性を低下する方法 |
| EP4533094A4 (en) * | 2022-05-25 | 2026-05-06 | Univ Houston System | Methods and systems for risk stratification and management of bladder cancer |
| TWI869873B (zh) * | 2023-06-05 | 2025-01-11 | 中國醫藥大學 | 一種檢測一個體罹患單純復發性風濕病的方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5998172A (en) * | 1993-11-02 | 1999-12-07 | Duke University | Anti-CD6 ligand antibodies |
| CU22615A1 (es) | 1994-06-30 | 2000-02-10 | Centro Inmunologia Molecular | Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos |
| CU22584A1 (es) | 1995-11-17 | 1999-11-03 | Centro Inmunologia Molecular | Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis |
| WO1998043089A1 (en) * | 1997-03-03 | 1998-10-01 | Bristol-Myers Squibb Company | Monoclonal antibodies to human cd6 |
| KR101482959B1 (ko) | 2006-12-26 | 2015-01-15 | 센트로 데 인뮤놀러지아 모레큘러 | Ｂ-세포 만성 림프구성 백혈병의 진단 및 치료에 유용한 종양 세포에서 세포사멸을 유도할 수 있는 약학 조성물 |
| WO2009113083A1 (en) * | 2008-03-14 | 2009-09-17 | Biocon Limited | A monoclonal antibody and a method thereof |
| JP5900489B2 (ja) * | 2011-03-25 | 2016-04-06 | コニカミノルタ株式会社 | 免疫組織染色法、およびこれを用いた抗体医薬の有効性を判定する方法 |
| BR112013033988B1 (pt) * | 2011-07-01 | 2021-10-19 | Beckman Coulter, Inc. | Métodos de identificação e isolamento de uma ou mais populações de células t regulatórias imunossupressoras |
| AU2013229786B2 (en) * | 2012-03-08 | 2017-06-22 | Halozyme, Inc. | Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof |
| WO2015107501A1 (en) * | 2014-01-20 | 2015-07-23 | Ghiggeri Gian Marco | In vitro method for predicting, diagnosing and monitoring in therapeutic follow up lupus nephritis |
| EP3439658B1 (en) * | 2016-04-04 | 2021-11-24 | ChemoCentryx, Inc. | Soluble c5ar antagonists |
| WO2017214452A1 (en) * | 2016-06-08 | 2017-12-14 | Xencor, Inc. | Treatment of igg4-related diseases with anti-cd19 antibodies crossbinding to cd32b |
| ES2991182T3 (es) * | 2016-10-21 | 2024-12-02 | Biocon Ltd | Un anticuerpo monoclonal y un método de uso para el tratamiento del lupus |
-
2020
- 2020-02-26 BR BR112021016967A patent/BR112021016967A2/pt unknown
- 2020-02-26 SG SG11202109118XA patent/SG11202109118XA/en unknown
- 2020-02-26 CN CN202080016831.1A patent/CN113490511B/zh active Active
- 2020-02-26 JP JP2021549772A patent/JP2022521973A/ja not_active Ceased
- 2020-02-26 US US17/434,247 patent/US20220143140A1/en not_active Abandoned
- 2020-02-26 CA CA3131299A patent/CA3131299A1/en active Pending
- 2020-02-26 WO PCT/US2020/019990 patent/WO2020176682A1/en not_active Ceased
- 2020-02-26 EP EP20714769.5A patent/EP3930751A1/en active Pending
- 2020-02-26 AU AU2020229830A patent/AU2020229830A1/en active Pending
- 2020-02-26 PH PH1/2021/551994A patent/PH12021551994A1/en unknown
- 2020-02-26 MX MX2021010283A patent/MX2021010283A/es unknown
-
2021
- 2021-09-22 ZA ZA2021/07077A patent/ZA202107077B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10822403B2 (en) | Composition and method for the diagnosis and treatment of iron-related disorders | |
| JP2022521973A5 (enExample) | ||
| RU2636345C2 (ru) | Новое антитело к cxcr4 и его применение для выявления и диагностики рака | |
| JP6138780B2 (ja) | 癌の検出および診断のための抗体ｉ−３８５９の使用 | |
| CA3091801A1 (en) | B7-h4 antibodies and methods of use thereof | |
| JP2017524362A5 (enExample) | ||
| EP3589652B1 (en) | Recombinant antibodies to programmed death 1 (pd-1) and uses therefor | |
| CN114650866B (zh) | 新的用于诊断的分子 | |
| KR20190130506A (ko) | 골수유래억제세포 관련 질환의 예방 및 치료 용도 | |
| JP2025533015A (ja) | 薬物抵抗性肝細胞癌の処置 | |
| US11009507B2 (en) | Methods and diagnostics for cancer detection and treatment monitoring | |
| KR20180118151A (ko) | 다발성 골수종에서 m-단백질 반응의 임상 평가 | |
| JP7300687B2 (ja) | 肝細胞癌診断用バイオマーカーセレブロンと、これに特異的な新規なモノクローナル抗体 | |
| US20230287512A1 (en) | Marker for response to pd-1/pd-l1 immunotherapy | |
| EP4471057A1 (en) | Anti-human cxcl1 antibody | |
| US20230093265A1 (en) | New method and compound for prostate cancer diagnosis | |
| TWI869740B (zh) | 一種體外檢測ｓＴＮＦＲ２蛋白濃度的方法及其檢測試劑和檢測試劑盒 | |
| CN110891604B (zh) | 靶向人TAXILINα的单克隆抗体及其使用方法 | |
| US10823735B2 (en) | Monoclonal antibody for predicting tamoxifen response in breast cancer patients | |
| JP4851620B2 (ja) | Ｎｋ４に対するモノクローナル抗体 | |
| CN118684779A (zh) | 一种抗Trop2单克隆抗体药物或其衍生物的特异性结合剂及其应用 | |
| RU2025105360A (ru) | Связывание антител с рецептором тиреотропного гормона и их применение | |
| CN116710575A (zh) | 对pd-1/pd-l1免疫疗法有反应的标志物 | |
| NZ749138A (en) | Monoclonal antibodies, compositions and methods for detecting mucin -like protein (mlp) as a biomarker for ovarian and pancreatic cancer | |
| NZ749138B2 (en) | Monoclonal antibodies, compositions and methods for detecting mucin -like protein (mlp) as a biomarker for ovarian and pancreatic cancer |